{"id":57081,"date":"2023-03-31T16:00:37","date_gmt":"2023-03-31T13:00:37","guid":{"rendered":"https:\/\/milliycha.uz\/?p=57081"},"modified":"2023-03-31T16:00:39","modified_gmt":"2023-03-31T13:00:39","slug":"balansli-qiymat","status":"publish","type":"post","link":"https:\/\/milliycha.uz\/ru\/balansli-qiymat\/","title":{"rendered":"BALANSLI QIYMAT"},"content":{"rendered":"\n<p>BALANSLI QIYMAT &#8212; 1. Uzoq muddatli aktivning yig&#8217;ilib qolgan eskirish qiymati chegirib tashlangandan keyingi qoladigan dastlabki qiymati (o&#8217;z kapitalning kamyob majburiyat va moddalari); yanada kengroq ma\u2019noda &#8212; tegishli schyotning qoldiq kamayishini hisobga olgan holdagi mazkur aktiv qiymati. 2. Kompaniyaning balans qiymati; majburiyatlar yig&#8217;indisi chegirib tashlangandan keyin qoladigan sof aktivlar va yig&#8217;ma aktivlari; xususiy kapital. 3. Aksiyaning balans qiymati; kompaniyaning hisob-kitob hujjatlari asosida aniqlanadi; kompaniyaning yig&#8217;ma aktivlari va yig&#8217;ma majburiyatlari o&#8217;rtasidagi farqqa imtiyozlashtirilgan qimmatli qo&#8217;g&#8217;ozlarning tugatilish qiymati, muomalaga kiritish uchun chiqarilgan oddiy aksiyalar soniga taqsimlab olingan summa, u oddiy aksiyalarning balans qiymatidan iborat bo&#8217;ladi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BALANSLI QIYMAT &#8212; 1. Uzoq muddatli aktivning yig&#8217;ilib qolgan eskirish qiymati chegirib tashlangandan keyingi qoladigan dastlabki qiymati (o&#8217;z kapitalning kamyob majburiyat va moddalari); yanada kengroq ma\u2019noda &#8212; tegishli schyotning qoldiq &hellip; <a href=\"https:\/\/milliycha.uz\/ru\/balansli-qiymat\/\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":56191,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[261],"tags":[],"class_list":["post-57081","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-b-harfiga-oid-iqtisodiy-ensiklopedik-atamalar","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"ru","enabled_languages":["uz","kr","ru"],"languages":{"uz":{"title":true,"content":true,"excerpt":false},"kr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/posts\/57081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/comments?post=57081"}],"version-history":[{"count":1,"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/posts\/57081\/revisions"}],"predecessor-version":[{"id":57102,"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/posts\/57081\/revisions\/57102"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/media\/56191"}],"wp:attachment":[{"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/media?parent=57081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/categories?post=57081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/milliycha.uz\/ru\/wp-json\/wp\/v2\/tags?post=57081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}